© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 371,437 results that match your search.371,437 results
  • EuroWeek has learned that Spanish pharmaceutical group Grifols is planning to float in the coming months. Morgan Stanley is likely to gain the mandate for the IPO, which will be the company's third attempt to list in recent years. Under the name Probitas Pharma, it tried to list in 2002 and 2004, with BBVA, Deutsche Bank and Santander Central Hispano (SCH) as bookrunners for the latter attempt. But it was forced to cancel both deals due to adverse market conditions.
  • Merrill Lynch and UBS have launched a Sfr84.5m ($64.3m) share placing for Speedel, the Swiss biotech company which makes renin inhibitors for treating heart disease.
  • Mitsubishi UFJ Financial Group launched a titanic tier one capital issue into stormy seas this week, but by widening pricing on the dollar and euro tranches, steered it to a successful conclusion, raising $4.2bn (¥496bn).
  • Mitsubishi UFJ Financial Group launched a titanic tier one capital issue into stormy seas this week, but by widening pricing on the dollar and euro tranches, steered it to a successful conclusion, raising $4.2bn (¥496bn).
  • Mitsubishi UFJ Financial Group launched a titanic tier one capital issue into stormy seas this week, but by widening pricing on the dollar and euro tranches, steered it to a successful conclusion, raising $4.2bn (¥496bn).
  • Mitsubishi UFJ Financial Group launched a titanic tier one capital issue into stormy seas this week, but by widening pricing on the dollar and euro tranches, steered it to a successful conclusion, raising $4.2bn (¥496bn).
  • Barclays Capital and Merrill Lynch expect to launch the debt backing CapVest Equity Partners' circa $665m buy-out of frozen food company Findus next week. The bank meeting is scheduled for March 16. EQT is selling the company which it acquired from Nestlé in 2000.
  • Credit Suisse has closed syndication of the debt backing the acquisition of woodflooring company Nybron. The loan should be allocated by next week. The debt includes a seven year term loan 'A' that yields 225bp, an eight year term loan 'B' that pays 275bp and a nine year term loan 'C' that has a 325bp margin. All three facilities are worth Eu95m. The 'B' and 'C' slices have a 50% institutional carve-out.
  • Farmers supply and crop marketing association Svenska Lantmännen is in the market with an Skr5bn revolver. Mandated lead arrangers Handelsbanken Capital Markets, Nordea Bank and Svenska Handelsbanken are targeting relationship banks on a take and hold basis.
  • Royal Bank of Scotland took silver in league table one this week, knocking Barclays Capital into third place, by leading four deals worth around $500m. Two of its deals included a $10m 10 year swap rate linked note for Commonwealth Bank of Australia and a Eu200m two year note for RCI Banque at 10bp over Euribor.
  • The Eu7.5bn management-approved leveraged buy-out of Dutch media group VNU was thrown into disarray when majority shareholders expressed doubt over the price. Fidelity, owners of about 15% of VNU shares, said it was "unlikely to support this offer". And Knight Vinke Asset Management, which controls about 2%, rejected the offer stating that it "substantially undervalued the company".